Pathway Diagnostics: Biomarker Development, Testing and Commercialization Ask Us How

Clinical Trials

Pathway Diagnostics provides cutting edge biomarker assay development, validation and testing services to pharma and biotech companies in clinical trials testing and development.

Learn more about our consultative support for the incorporation of biomarkers into clinical study design and Biomarker Selection.

Apply our unique expertise in Custom Assay Development including customized assay validation reports.

We are able to offer the flexibility of sample management directly with sponsors and/or through their CROs or central labs. Review our trial-specific Project Management.

Search our Central Laboratory Capabilities.

The laboratory is CLIA- and CAP-certified and compliant with applicable GLP and GCP guidelines. View our Laboratory Licensure.

Have a specific question about how to unleash the potential of biomarkers to enhance your clinical trial data?

ASK US HOW

What's New "Announcing SensiTrop™ II HIV co-receptor tropism assay, combining the sensitivity of heteroduplex tracking and the specificity of DNA sequence analysis "
©2009 Quest Diagnostics. Privacy Policy.